Synergistic effect of melatonin and ghrelin in preventing cisplatin ‐induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles

In conclusion, these findings suggest that melatonin and ghrelin co‐administration is suitable for use as a fertoprotective adjuvant therapy during cisplatin chemotherapy in young female cancer patients. This article is protected by copyright. All rights reserved.
Source: Journal of Pineal Research - Category: Research Authors: Tags: Original Article Source Type: research